Osteoporosis Can Be Prevented Without Side Effects

Introducing OsteoBoost, the first vibration belt specifically designed to treat osteopenia and prevent osteoporosis.

There is an Escalating Rate of Osteoporosis Despite 20 Years of Drug Treatment Options

1 in 2 women and 1 in 4 men over 50 will suffer an osteoporosis related fracture



“Fearing Drugs’ Rare Side Effects, Millions Take their Chances With Osteoporosis”

— New York Times

Introducing OsteoBoost

OsteoBoost is the first vibration belt specifically designed for the prevention of osteoporosis.

SIMPLE YET EFFECTIVE

The OsteoBoost Vibration Belt applies gentle mechanical stimulation to the hips and spine to reduce bone loss and encourage bone growth.

BASED ON NASA RESEARCH

Leveraging 15 years of published research (starting with NASA) proving that vibration at a precise amplitude and frequency stimulates bones, OsteoBoost delivers the optimal therapeutic dose directly to the most vulnerable anatomy, the hips and spine.

CLINICAL RESEARCH

Currently being studied in a National Institutes of Health (NIH) funded clinical trial, based on a successful pilot study that showed a significant reduction in bone loss after just one treatment.

EASY AND CONVENIENT

Comfortable and as easy as putting on a belt, one 30 minute treatment per day while doing chores or walking the dog makes OsteoBoost easy to fit into any lifestyle.

Comparing Bone Mineral Density

There are over 1 million hip and spine fractures each year with the onset of osteoporosis

Many fractures could be prevented by mechanically stimulating the bones.

Bone health improvement potential based on recent study
(abstract published by the Orthopedic Research Society in 2018)

5-10 years of OsteoBoost treatment can delay the onset of osteoporosis by 20-25 years. 

The OsteoBoost Difference

REDUCTION IN BONE LOSS ACTIVITY

In a recently published study, OsteoBoost induced an acute reduction in bone loss activity as measured by the biomarker NTx (mean: 14%, p<0.001).

COMPARABLE TO MEDICATION AND EXERCISE

Study results are consistent with the effects of high-impact exercise and osteoporosis medication.

GREAT PREVENTATIVE MEASURE

OsteoBoost can be used during osteopenia whereas the medications are only approved for osteoporosis.

HIGH COMPLIANCE

Compliance is high at over 80%.

Treatment Compliance Rate

 Current medication treatments are underutilized with 75% of patients discontinuing their medication within 12 months.

OsteoBoost is easy and convenient to use, with high compliance and satisfaction ratings. 

Compliance

How It Works

The OsteoBoost Vibration Belt is as simple as 1-2-3, and includes an auto-shutoff feature that ends treatment after 30 minutes. Use daily or at least 4 days a week for full treatment effect.

Easy to attach velcro secures it around the waist.

STEP 1

Simply press power and it begins the gentle vibration treatment.

STEP 2

Once treatment beings, you can go about your business.

STEP 3

Chan et al., 2013. The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr Osteoporos Rep 11: p. 36-44. 

NASA Research Leads to Vibration Belt Technology

Developed from NASA proven technology, OsteoBoost takes vibration therapy to another level by delivering precise mechanical stimulation to the areas of the body that need it most, the hips and spine.

Our Team

Laura Yecies

CEO

Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo.

Michael Jaasma

CTO

PhD from UC Berkeley in Orthopedics. Former Manager at FDA, Division of Orthopedic Devices. Over 10 years of medical device R&D experience.

Gabriel Griego

Marketing

Seasoned sales & marketing leader. Track-record of successfully designing and executing go-to-market for consumer/medical products. Led marketing for PowerBar, Game Ready, and AlterG.

Carin Lindquist

Clinical Operations

Experienced running over 10 clinical trials for several novel medical devices.

Board Members

Dan Burnett

Chairman

MD/MBA Duke, experienced medtech entrepreneur, founded 10 startups and generated >$225M in investment through his incubator TheraNova.

Karen Drexler

MBA, BSE

Founded and ran Amira Medical through the sale to Roche, Manager at LifeScan and executed the sale to J&J, CEO of Sandstone Diagnostics, guest lecturer at Stanford, active board member at a variety of major medical device/diagnostic companies. Engineering background with deep business and entrepreneurial experience.

Dr. Nancy Lynch

MD, MBA

President of Advisorthopædics, Board-certified orthopedic surgeon and fellow of the American Academy of Orthopædic Surgeons. B.A. from the University of Notre Dame, M.D. from the Washington University School of Medicine, completed residency at the Mayo Clinic and an MBA from Duke. Experience as a venture capitalist, and as an executive within startup companies.

Dr. Sam Goldberger

MD, MBA

Co-Founder and Managing Partner of Ambit Health Ventures. Ophthalmologist and ophthalmic surgeon. Board certified by the American Academy of Ophthalmology and member of the American Society of Ophthalmic Plastic & Reconstructive Surgery. MD from Albert Einstein College of Medicine, and MBA from MIT Sloan. Led a successful ophthalmology practice roll up and founded a healthcare and life-science investing firm.

John Osborne

BS

Over a decade working various roles in the finance industry including in commercial banking, private banking and angel investing. Co-founded and Director of The Harbor Entrepreneur Center, Charleston. Executive Administrator of Charleston Angel Partners. B.S. in Finance from Charleston Southern University

Laura Yecies

CEO

Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo.

Michael Jaasma

CTO

PhD from UC Berkeley in Orthopedics. Former Manager at FDA, Division of Orthopedic Devices. Over 10 years of medical device R&D experience.

Advisors

Laura Bilek

PhD, PT

Associate Dean for Research in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC). Expert in clinical research for the treatment of low bone mass.

Shane Mangrum

MD

Physical Medicine and Rehabilitation (PM&R) physician at Polaris Spine in Atlanta, GA; Specialist in nonoperative spine and musculoskeletal care. Dr. Mangrum is also a co-inventor of the OsteoBoost technology.

Tony Keaveny

PhD

Professor of Mechanical Engineering and Bioengineering, UC Berkeley, director of the Berkeley Orthopaedic Biomechanics Lab; Expert in bone mechanics and inventor of VirtuOst.

Investors

Berkeley Angel Network

54 million Americans have osteopenia or osteoporosis

Now they have a good option to help prevent fractures
that is easy to use and fits into their daily lifestyle

Contact us

At this time OsteoBoost is not available for sale and the clinical trial is closed. Please fill out the form if you would like to be notified when the product is available.

* indicates required
Are you interested in being part of a clinical trial? *